Patents by Inventor Hyoju Choi

Hyoju Choi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250145718
    Abstract: The present disclosure provides a polynucleotide encoding the anti-PD-L1/anti-4-1BB bispecific antibody capable to effectively block the interactions between PD-L1 and its receptor PD-1 and between 4-1BB and its ligand. The bispecific antibody may have high binding affinity to both of a PD-L1 protein and a 4-1BB protein.
    Type: Application
    Filed: January 7, 2025
    Publication date: May 8, 2025
    Applicants: ABL BIO INC., I-MAB BIOPHARMA US LIMITED
    Inventors: Eunyoung PARK, Yangsoon LEE, Hyejin CHUNG, Eunsil SUNG, Jiseon YOO, Minji PARK, Yong-Gyu SON, Hyoju CHOI, Eunjung KIM, Jaeho JUNG, Weon-Kyoo YOU, Sang Hoon LEE, Lei FANG, Wenqing JIANG
  • Publication number: 20250066487
    Abstract: Provided are an anti-4-1BB/anti-EGFR bispecific antibody, and a pharmaceutical composition and a method for treating and/or preventing a cancer using the same.
    Type: Application
    Filed: November 4, 2024
    Publication date: February 27, 2025
    Inventors: Yeryoung YONG, Ui-Jung JUNG, Hyejin CHUNG, Kyeongsu PARK, Wonjun SON, Yangsoon LEE, Yeunju KIM, Eunsil SUNG, Youngkwang KIM, Youngdon PAK, Minji PARK, Jaehyun EOM, Hyoju CHOI, Moo Young SONG, Na Rae LEE, Young Bong PARK, Eun-Jung LEE, Eun-Jung LEE
  • Patent number: 12195538
    Abstract: The present disclosure provides an anti-PD-L1/anti-4-1BB bispecific antibody capable to effectively block the interactions between PD-L1 and its receptor PD-1 and between 4-1BB and its ligand. The bispecific antibody may have high binding affinity to both of a PD-L1 protein and a 4-1BB protein.
    Type: Grant
    Filed: February 15, 2019
    Date of Patent: January 14, 2025
    Assignees: ABL BIO INC., I-MAB BIOPHARMA US LIMITED
    Inventors: Eunyoung Park, Yangsoon Lee, Hyejin Chung, Eunsil Sung, Jiseon Yoo, Minji Park, Yong-Gyu Son, Hyoju Choi, Eunjung Kim, Jaeho Jung, Weon-Kyoo You, Sang Hoon Lee, Lei Fang, Wenqing Jiang
  • Patent number: 12168690
    Abstract: Provided are an anti-4-1BB/anti-EGFR bispecific antibody, and a pharmaceutical composition and a method for treating and/or preventing a cancer using the same.
    Type: Grant
    Filed: July 27, 2020
    Date of Patent: December 17, 2024
    Assignees: ABL BIO INC., YUHAN CORPORATION
    Inventors: Yeryoung Yong, Ui-Jung Jung, Hyejin Chung, Kyeongsu Park, Wonjun Son, Yangsoon Lee, Yeunju Kim, Eunsil Sung, Youngkwang Kim, Youngdon Pak, Minji Park, Jaehyun Eom, Hyoju Choi, Moo Young Song, Na Rae Lee, Young Bong Park, Eun-Jung Lee, Eun-Jung Lee
  • Publication number: 20220056136
    Abstract: The present disclosure provides an anti-PD-L1/anti-4-1BB bispecific antibody capable to effectively block the interactions between PD-L1 and its receptor PD-1 and between 4-1BB and its ligand. The bispecific antibody may have high binding affinity to both of a PD-L1 protein and a 4-1BB protein.
    Type: Application
    Filed: February 15, 2019
    Publication date: February 24, 2022
    Applicants: ABL BIO INC., I-MAB BIOPHARMA CO., LTD
    Inventors: Eunyoung PARK, Yangsoon LEE, Hyejin CHUNG, Eunsil SUNG, Jiseon YOO, Minji PARK, Yong-Gyu SON, Hyoju CHOI, Eunjung KIM, Jaeho JUNG, Weon-Kyoo YOU, Sang Hoon LEE, Lei FANG, Wenqing JIANG
  • Publication number: 20210024638
    Abstract: Provided are an anti-4-1BB/anti-EGFR bispecific antibody, and a pharmaceutical composition and a method for treating and/or preventing a cancer using the same.
    Type: Application
    Filed: July 27, 2020
    Publication date: January 28, 2021
    Inventors: Yeryoung Yong, Ui-Jung Jung, Hyejin Chung, Kyeongsu Park, Wonjun Son, Yangsoon Lee, Yeunju Kim, Eunsil Sung, Youngkwang Kim, Youngdon Pak, Minji Park, Jaehyun Eom, Hyoju Choi, Moo Young Song, Na Rae Lee, Young Bong Park, Eun-Jung Lee, Eun-Jung Lee